Id |
Subject |
Object |
Predicate |
Lexical cue |
T2 |
4-12 |
NN |
denotes |
planning |
T3 |
13-15 |
IN |
denotes |
of |
T4 |
16-24 |
NN |
denotes |
COVID-19 |
T5 |
24-25 |
-COLON- |
denotes |
: |
T6 |
26-35 |
NN |
denotes |
Rationale |
T7 |
36-39 |
CC |
denotes |
and |
T8 |
40-50 |
NN |
denotes |
hypothesis |
T9 |
51-54 |
IN |
denotes |
for |
T10 |
55-58 |
DT |
denotes |
the |
T11 |
59-62 |
NN |
denotes |
use |
T12 |
63-65 |
IN |
denotes |
of |
T13 |
66-74 |
JJ |
denotes |
multiple |
T14 |
75-92 |
JJ |
denotes |
immunosuppressive |
T15 |
93-99 |
NNS |
denotes |
agents |
T16 |
99-100 |
-COLON- |
denotes |
: |
T17 |
101-116 |
NNS |
denotes |
Anti-antibodies |
T18 |
116-117 |
-COMMA- |
denotes |
, |
T19 |
118-133 |
NNS |
denotes |
immunoglobulins |
T20 |
133-134 |
-COMMA- |
denotes |
, |
T21 |
135-138 |
CC |
denotes |
and |
T22 |
139-154 |
NNS |
denotes |
corticosteroids |
T23 |
156-166 |
NNS |
denotes |
Highlights |
T24 |
167-168 |
IN |
denotes |
• |
T25 |
170-174 |
NNP |
denotes |
IVIG |
T26 |
174-175 |
-COMMA- |
denotes |
, |
R10 |
T11 |
T12 |
arg1Of |
use,of |
R11 |
T15 |
T12 |
arg2Of |
agents,of |
R12 |
T15 |
T13 |
arg1Of |
agents,multiple |
R13 |
T15 |
T14 |
arg1Of |
agents,immunosuppressive |
R14 |
T7 |
T16 |
arg1Of |
and,: |
R15 |
T17 |
T18 |
arg1Of |
Anti-antibodies,"," |
R16 |
T19 |
T18 |
arg2Of |
immunoglobulins,"," |
R17 |
T21 |
T20 |
arg1Of |
and,"," |
R18 |
T18 |
T21 |
arg1Of |
",",and |
R19 |
T22 |
T21 |
arg2Of |
corticosteroids,and |
R2 |
T2 |
T3 |
arg1Of |
planning,of |
R20 |
T25 |
T24 |
arg1Of |
IVIG,• |
R21 |
T25 |
T26 |
arg1Of |
IVIG,"," |
R3 |
T4 |
T3 |
arg2Of |
COVID-19,of |
R4 |
T2 |
T5 |
arg1Of |
planning,: |
R5 |
T6 |
T7 |
arg1Of |
Rationale,and |
R6 |
T8 |
T7 |
arg2Of |
hypothesis,and |
R7 |
T7 |
T9 |
arg1Of |
and,for |
R8 |
T11 |
T9 |
arg2Of |
use,for |
R9 |
T11 |
T10 |
arg1Of |
use,the |